EV Biologics, Inc. (YECO)
OTCMKTS
· Delayed Price · Currency is USD
0.0912
+0.0022 (2.51%)
At close: Jul 2, 2025
EV Biologics Revenue
In the year 2017, EV Biologics had annual revenue of $9.47M, down -0.34%. EV Biologics had revenue of $2.46M in the quarter ending June 30, 2017, a decrease of -78.05%.
Revenue
9.47M
Revenue Growth
-70.48%
P/S Ratio
0.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
932.86K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 84.04M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
EV Biologics News
- 1 year ago - EV Biologics Updates on Funding and Sales - Accesswire
- 2 years ago - EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic - Accesswire
- 2 years ago - EV Biologics Appoints Senior Investment Banker as Corporate Finance Director - Accesswire
- 2 years ago - EV Biologics Hires Senior Chief Financial Officer - Accesswire
- 2 years ago - EV Biologics Signs Exclusive Distribution Agreement for South America - Accesswire
- 2 years ago - EV Biologics Generates Mesenchymal Stem Cell Lines - Accesswire
- 2 years ago - EV Biologics Updates on Excyte Subsidiary Funding - Accesswire
- 2 years ago - EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX - Accesswire